{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:11:52Z","timestamp":1781885512923,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,21]]},"DOI":"10.7759\/cureus.22463","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:39:40Z","timestamp":1645479580000},"source":"Crossref","is-referenced-by-count":2,"title":["A Single Axial Slice of the Sternocleidomastoids and Paravertebral Muscles Associated with Worse Local Progression-Free Survival and Severe Toxicity in Sarcopenic Head and Neck Cancer Patients Undergoing Radiotherapy"],"prefix":"10.7759","author":[{"given":"William","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Yechieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart E","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein DJ","year":"2003","unstructured":"Adelstein DJ, Li Y, Adams GL, et al.. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003, 21:92-8. 10.1200\/JCO.2003.01.008","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2679-4","article-title":"Relationship between TNF-\u03b1 -1031T\/C gene polymorphism, plasma level of TNF-\u03b1, and risk of cachexia in head and neck cancer patients","volume":"144","author":"Powr\u00f3zek T","year":"2018","unstructured":"Powr\u00f3zek T, Mlak R, Brzozowska A, Mazurek M, Go\u0142\u0119biowski P, Ma\u0142ecka-Massalska T. Relationship between TNF-\u03b1 -1031T\/C gene polymorphism, plasma level of TNF-\u03b1, and risk of cachexia in head and neck cancer patients. J Cancer Res Clin Oncol. 2018, 144:1423-34. 10.1007\/s00432-018-2679-4","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2004.10.003","article-title":"Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia","volume":"37","author":"Argil\u00e9s JM","year":"2005","unstructured":"Argil\u00e9s JM, Busquets S, Felipe A, L\u00f3pez-Soriano FJ. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. Int J Biochem Cell Biol. 2005, 37:1084-104. 10.1016\/j.biocel.2004.10.003","journal-title":"Int J Biochem Cell Biol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23696","article-title":"Cancer cachexia update in head and neck cancer: pathophysiology and treatment","volume":"37","author":"Couch ME","year":"2015","unstructured":"Couch ME, Dittus K, Toth MJ, et al.. Cancer cachexia update in head and neck cancer: pathophysiology and treatment. Head Neck. 2015, 37:1057-72. 10.1002\/hed.23696","journal-title":"Head Neck"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia","volume":"11","author":"Peixoto da Silva S","year":"2020","unstructured":"Peixoto da Silva S, Santos JM, Costa E Silva MP, Gil da Costa RM, Medeiros R. Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle. 2020, 11:619-35. 10.1002\/jcsm.12528","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2020.10.002","article-title":"Sarcopenia measured with handgrip strength and skeletal muscle mass to assess frailty in older patients with head and neck cancer","volume":"12","author":"Meerkerk CD","year":"2021","unstructured":"Meerkerk CD, Chargi N, de Jong PA, van den Bos F, de Bree R. Sarcopenia measured with handgrip strength and skeletal muscle mass to assess frailty in older patients with head and neck cancer. J Geriatr Oncol. 2021, 12:434-40. 10.1016\/j.jgo.2020.10.002","journal-title":"J Geriatr Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24672","article-title":"Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma","volume":"39","author":"Kwon M","year":"2017","unstructured":"Kwon M, Kim RB, Roh JL, et al.. Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma. Head Neck. 2017, 39:716-23. 10.1002\/hed.24672","journal-title":"Head Neck"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/00016489.2016.1277263","article-title":"Cachexia at diagnosis is associated with poor survival in head and neck cancer patients","volume":"137","author":"Orell-Kotikangas H","year":"2017","unstructured":"Orell-Kotikangas H, \u00d6sterlund P, M\u00e4kitie O, Saarilahti K, Ravasco P, Schwab U, M\u00e4kitie AA. Cachexia at diagnosis is associated with poor survival in head and neck cancer patients. Acta Otolaryngol. 2017, 137:778-85. 10.1080\/00016489.2016.1277263","journal-title":"Acta Otolaryngol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00457","article-title":"Prognostic significance of sarcopenia with inflammation in patients with head and neck cancer who underwent definitive chemoradiotherapy","volume":"8","author":"Cho Y","year":"2018","unstructured":"Cho Y, Kim JW, Keum KC, Lee CG, Jeung HC, Lee IJ. Prognostic significance of sarcopenia with inflammation in patients with head and neck cancer who underwent definitive chemoradiotherapy. Front Oncol. 2018, 8:457. 10.3389\/fonc.2018.00457","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2019.04.023","article-title":"The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation","volume":"137","author":"Ganju RG","year":"2019","unstructured":"Ganju RG, Morse R, Hoover A, TenNapel M, Lominska CE. The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation. Radiother Oncol. 2019, 137:117-24. 10.1016\/j.radonc.2019.04.023","journal-title":"Radiother Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-012-1923-5","article-title":"Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma","volume":"16","author":"Peng P","year":"2012","unstructured":"Peng P, Hyder O, Firoozmand A, et al.. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012, 16:1478-86. 10.1007\/s11605-012-1923-5","journal-title":"J Gastrointest Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2017.09.13","article-title":"Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy","volume":"9","author":"Jin WH","year":"2018","unstructured":"Jin WH, Mellon EA, Frakes JM, et al.. Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy. J Gastrointest Oncol. 2018, 9:24-34. 10.21037\/jgo.2017.09.13","journal-title":"J Gastrointest Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2017.06.11","article-title":"Impact of sarcopenia on outcomes of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation followed by surgery","volume":"8","author":"Murimwa GZ","year":"2017","unstructured":"Murimwa GZ, Venkat PS, Jin W, et al.. Impact of sarcopenia on outcomes of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation followed by surgery. J Gastrointest Oncol. 2017, 8:808-15. 10.21037\/jgo.2017.06.11","journal-title":"J Gastrointest Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-017-1564-0","article-title":"Sarcopenia is an independent predictor of complications after colorectal cancer surgery","volume":"48","author":"Nakanishi R","year":"2018","unstructured":"Nakanishi R, Oki E, Sasaki S, et al.. Sarcopenia is an independent predictor of complications after colorectal cancer surgery. Surg Today. 2018, 48:151-7. 10.1007\/s00595-017-1564-0","journal-title":"Surg Today"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232371","article-title":"Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma","volume":"15","author":"Lanza E","year":"2020","unstructured":"Lanza E, Masetti C, Messana G, et al.. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma. PLoS One. 2020, 15:e0232371. 10.1371\/journal.pone.0232371","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2014.894103","article-title":"Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer","volume":"66","author":"Barret M","year":"2014","unstructured":"Barret M, Antoun S, Dalban C, et al.. Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. Nutr Cancer. 2014, 66:583-9. 10.1080\/01635581.2014.894103","journal-title":"Nutr Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4281-6","article-title":"Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer","volume":"22","author":"Miyamoto Y","year":"2015","unstructured":"Miyamoto Y, Baba Y, Sakamoto Y, et al.. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol. 2015, 22:2663-8. 10.1245\/s10434-014-4281-6","journal-title":"Ann Surg Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado CM","year":"2009","unstructured":"Prado CM, Baracos VE, McCargar LJ, et al.. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009, 15:2920-6. 10.1158\/1078-0432.CCR-08-2242","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan BH","year":"2009","unstructured":"Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009, 15:6973-9. 10.1158\/1078-0432.CCR-09-1525","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.12788","article-title":"Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: impact on survival, treatment completion, hospital admission and cost","volume":"33","author":"Findlay M","year":"2020","unstructured":"Findlay M, Brown C, De Abreu Louren\u00e7o R, White K, Bauer J. Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: impact on survival, treatment completion, hospital admission and cost. J Hum Nutr Diet. 2020, 33:811-21. 10.1111\/jhn.12788","journal-title":"J Hum Nutr Diet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2016.09.006","article-title":"Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients","volume":"62","author":"Swartz JE","year":"2016","unstructured":"Swartz JE, Pothen AJ, Wegner I, et al.. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol. 2016, 62:28-33. 10.1016\/j.oraloncology.2016.09.006","journal-title":"Oral Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12443","article-title":"CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer","volume":"10","author":"Zwart AT","year":"2019","unstructured":"Zwart AT, van der Hoorn A, van Ooijen PM, Steenbakkers RJ, de Bock GH, Halmos GB. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer. J Cachexia Sarcopenia Muscle. 2019, 10:1060-9. 10.1002\/jcsm.12443","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.21053\/ceo.2018.01613","article-title":"Diagnosis of sarcopenia in head and beck computed tomography: cervical muscle mass as a strong indicator of sarcopenia","volume":"12","author":"Ufuk F","year":"2019","unstructured":"Ufuk F, Herek D, Y\u00fcksel D. Diagnosis of sarcopenia in head and beck computed tomography: cervical muscle mass as a strong indicator of sarcopenia. Clin Exp Otorhinolaryngol. 2019, 12:317-24. 10.21053\/ceo.2018.01613","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25420","article-title":"Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer","volume":"41","author":"Fattouh M","year":"2019","unstructured":"Fattouh M, Chang GY, Ow TJ, et al.. Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer. Head Neck. 2019, 41:707-14. 10.1002\/hed.25420","journal-title":"Head Neck"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1200\/OP.20.00777","article-title":"Disparities in characteristics, access to care, and oncologic outcomes in young-onset colorectal cancer at a safety-net hospital","volume":"17","author":"Fangman BD","year":"2021","unstructured":"Fangman BD, Goksu SY, Chowattukunnel N, et al.. Disparities in characteristics, access to care, and oncologic outcomes in young-onset colorectal cancer at a safety-net hospital. JCO Oncol Pract. 2021, 17:e614-22. 10.1200\/OP.20.00777","journal-title":"JCO Oncol Pract"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/lary.29197","article-title":"Explaining racial disparities in surgically treated head and neck cancer","volume":"131","author":"Jassal JS","year":"2021","unstructured":"Jassal JS, Cramer JD. Explaining racial disparities in surgically treated head and neck cancer. Laryngoscope. 2021, 131:1053-9. 10.1002\/lary.29197","journal-title":"Laryngoscope"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25938","article-title":"Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer","volume":"41","author":"Karsten RT","year":"2019","unstructured":"Karsten RT, Al-Mamgani A, Bril SI, et al.. Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer. Head Neck. 2019, 41:4000-8. 10.1002\/hed.25938","journal-title":"Head Neck"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2017-001440","article-title":"Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial","volume":"8","author":"Solheim TS","year":"2018","unstructured":"Solheim TS, Laird BJ, Balstad TR, et al.. Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial. BMJ Support Palliat Care. 2018, 8:258-65. 10.1136\/bmjspcare-2017-001440","journal-title":"BMJ Support Palliat Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/86708-a-single-axial-slice-of-the-sternocleidomastoids-and-paravertebral-muscles-associated-with-worse-local-progression-free-survival-and-severe-toxicity-in-sarcopenic-head-and-neck-cancer-patients-undergoing-radiotherapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:42Z","timestamp":1707507942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/86708-a-single-axial-slice-of-the-sternocleidomastoids-and-paravertebral-muscles-associated-with-worse-local-progression-free-survival-and-severe-toxicity-in-sarcopenic-head-and-neck-cancer-patients-undergoing-radiotherapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.22463","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,21]]}}}